Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000108 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 15, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
21,000
Total Value
$574,887.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 35,271 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 38,771 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Oct 15, 2026 | Sale | 2,853 | $73.89 | $210,806.46 | 35,918 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Oct 15, 2026 | Sale | 1,847 | $74.69 | $137,956.86 | 34,071 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Oct 15, 2026 | Sale | 1,400 | $75.48 | $105,676.76 | 32,671 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Oct 15, 2026 | Sale | 700 | $76.67 | $53,665.64 | 31,971 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Oct 15, 2026 | Sale | 200 | $77.71 | $15,542.00 | 31,771 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 190,063 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 161,492 | Direct | โ | View Details |